CanadaBis Capital Inc (CANB) - Net Assets
Based on the latest financial reports, CanadaBis Capital Inc (CANB) has net assets worth CA$7.80 Million CAD (≈ $5.64 Million USD) as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$24.43 Million ≈ $17.67 Million USD) and total liabilities (CA$16.64 Million ≈ $12.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CANB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$7.80 Million |
| % of Total Assets | 31.91% |
| Annual Growth Rate | 55.4% |
| 5-Year Change | 335.08% |
| 10-Year Change | N/A |
| Growth Volatility | 250.41 |
CanadaBis Capital Inc - Net Assets Trend (2016–2025)
This chart illustrates how CanadaBis Capital Inc's net assets have evolved over time, based on quarterly financial data. Also explore CanadaBis Capital Inc (CANB) total assets for the complete picture of this company's asset base.
Annual Net Assets for CanadaBis Capital Inc (2016–2025)
The table below shows the annual net assets of CanadaBis Capital Inc from 2016 to 2025. For live valuation and market cap data, see CanadaBis Capital Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-07-31 | CA$7.92 Million ≈ $5.73 Million |
+6.91% |
| 2024-07-31 | CA$7.41 Million ≈ $5.36 Million |
+0.92% |
| 2023-07-31 | CA$7.34 Million ≈ $5.31 Million |
+178.86% |
| 2022-07-31 | CA$2.63 Million ≈ $1.91 Million |
+44.61% |
| 2021-07-31 | CA$1.82 Million ≈ $1.32 Million |
-46.96% |
| 2020-07-31 | CA$3.43 Million ≈ $2.48 Million |
+20.33% |
| 2019-07-31 | CA$2.85 Million ≈ $2.06 Million |
+799.61% |
| 2018-07-31 | CA$317.23K ≈ $229.48K |
-30.37% |
| 2017-07-31 | CA$455.59K ≈ $329.57K |
+203.73% |
| 2016-07-31 | CA$150.00K ≈ $108.51K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CanadaBis Capital Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1338737800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$21.22 Million | 270.96% |
| Total Equity | CA$7.83 Million | 100.00% |
CanadaBis Capital Inc Competitors by Market Cap
The table below lists competitors of CanadaBis Capital Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Quartix Holdings Plc
LSE:QTX
|
$1.53 Million |
|
Ramsdens Holdings PLC
LSE:RFX
|
$1.54 Million |
|
Hexima Ltd
AU:HXL
|
$1.54 Million |
|
Nextgen
TA:NXGN
|
$1.54 Million |
|
GEMINA LABS LTD
F:8I7
|
$1.53 Million |
|
DELPHI WORLD MONEY LIMITED
NSE:DELPHIFX
|
$1.53 Million |
|
Ngenic AB
ST:NGENIC
|
$1.53 Million |
|
CBEYOND
F:C5B
|
$1.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CanadaBis Capital Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,318,659 to 7,830,761, a change of 512,102 (7.0%).
- Net loss of 835,204 reduced equity.
- Other factors increased equity by 1,347,306.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-835.20K | -10.67% |
| Other Changes | CA$1.35 Million | +17.21% |
| Total Change | CA$- | 7.00% |
Book Value vs Market Value Analysis
This analysis compares CanadaBis Capital Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.26x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-07-31 | CA$0.07 | CA$0.02 | x |
| 2018-07-31 | CA$0.04 | CA$0.02 | x |
| 2019-07-31 | CA$0.03 | CA$0.02 | x |
| 2020-07-31 | CA$0.03 | CA$0.02 | x |
| 2021-07-31 | CA$0.01 | CA$0.02 | x |
| 2022-07-31 | CA$0.02 | CA$0.02 | x |
| 2023-07-31 | CA$0.05 | CA$0.02 | x |
| 2024-07-31 | CA$0.05 | CA$0.02 | x |
| 2025-07-31 | CA$0.06 | CA$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CanadaBis Capital Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.94%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 3.13x
- Recent ROE (-10.67%) is above the historical average (-70.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -35.67% | 0.00% | 0.00x | 1.03x | CA$-208.07K |
| 2018 | -43.61% | 0.00% | 0.00x | 1.10x | CA$-170.08K |
| 2019 | -315.46% | 0.00% | 0.00x | 1.88x | CA$-9.29 Million |
| 2020 | -161.52% | -121.68% | 0.35x | 3.75x | CA$-5.72 Million |
| 2021 | -154.93% | -38.98% | 0.52x | 7.69x | CA$-2.85 Million |
| 2022 | 23.95% | 5.21% | 0.75x | 6.09x | CA$354.28K |
| 2023 | 61.30% | 20.00% | 0.97x | 3.17x | CA$3.72 Million |
| 2024 | -1.15% | -0.47% | 0.73x | 3.35x | CA$-815.93K |
| 2025 | -10.67% | -4.94% | 0.69x | 3.13x | CA$-1.62 Million |
Industry Comparison
This section compares CanadaBis Capital Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $822,136,203
- Average return on equity (ROE) among peers: -45.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CanadaBis Capital Inc (CANB) | CA$7.80 Million | -35.67% | 2.13x | $1.53 Million |
| Aurora Cannabis Inc (ACB) | $601.87 Million | -11.52% | 0.39x | $193.63 Million |
| Amotiv Limited (AOV) | $915.11 Million | 1.59% | 0.43x | $553.67 Million |
| Aequus Pharmaceuticals Inc (AQS) | $-4.29 Million | 0.00% | 0.00x | $479.73K |
| Avicanna Inc (AVCN) | $841.07K | -309.08% | 1.52x | $13.17 Million |
| Avant Brands Inc (AVNT) | $-490.96K | 0.00% | 0.00x | $4.13 Million |
| Bausch Health Companies Inc (BHC) | $5.23 Billion | -16.55% | 4.34x | $2.06 Billion |
| Cannabist Company Holdings Inc (CBST) | $550.08 Million | -25.79% | 1.50x | $12.59 Million |
| Cipher Pharmaceuticals Inc (CPH) | $80.52 Million | 25.31% | 0.07x | $326.62 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $22.27 Million | -71.36% | 0.11x | $148.65 Million |
About CanadaBis Capital Inc
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products th… Read more